Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|10|2|139-158

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.10, Iss.2, 2012-06, pp. : 139-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The brain as a target for development of new class of drugs for the treatment of somatic diseases

By Mravec Boris  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 433-437

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-01 ,pp. : 135-145

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

By Ye Yumei   Long Bo   Qian Jinqiao   Perez-Polo Jose   Birnbaum Yochai  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 391-399

Springer Publishing Company

Access to resources Recommend Favorite

Antiglucocorticoid drugs in the treatment of depression

By Reus Victor I   Wolkowitz Owen M  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1789-1796

Informa Healthcare

Access to resources Recommend Favorite

Serotonergic Drugs for Depression and Beyond

By  

Current Drug Targets, Vol. 14, Iss. 5, 2013-05 ,pp. : 578-585

Bentham Science Publishers

Access to resources Recommend Favorite